1 – 15 of 15
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Needs of amyloidosis patients and their care providers : design & first results of the AMY-NEEDS research and care program
(
- Contribution to journal › Article
-
Mark
Single German centre experience with patient journey and care-relevant needs in amyloidosis : The German AMY-NEEDS research and care program
(
- Contribution to journal › Article
-
Mark
Liver stiffness as a prognostic parameter and tool for risk stratification in advanced cardiac transthyretin amyloidosis
2024) In Clinical Research in Cardiology(
- Contribution to journal › Article
-
Mark
Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis
2024) In Clinical Research in Cardiology(
- Contribution to journal › Article
-
Mark
Cardio-Hepatic Interaction in Cardiac Amyloidosis
(
- Contribution to journal › Article
- 2023
-
Mark
Vector autoregression : Useful in rare diseases?—Predicting organ response patterns in a rare case of secondary AA amyloidosis
(
- Contribution to journal › Article
- 2018
-
Mark
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
(
- Contribution to journal › Article
- 2016
-
Mark
Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
(
- Contribution to journal › Article
-
Mark
The european hematology association roadmap for european hematology research : A consensus document
(
- Contribution to journal › Article
- 2015
-
Mark
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
(
- Contribution to journal › Article
- 2013
-
Mark
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
(
- Contribution to journal › Article
- 2012
-
Mark
MyelomA Genetics International Consortium
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Large Granular Lymphocyte (LGL) Expansions Comprising Oligoclonal T Cell or NK Cell Populations in Dasatinib Treated Patients Are Associated with HLA-A*0201, CMV Reactivation and Enhanced Anti-Leukemic Control.
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-Term Follow-up of HCV Infected Stem Cell Transplant Patients and Effects of Antiviral Therapy.
(
- Contribution to journal › Published meeting abstract